Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
London, UK, May 12, 2021 (GLOBE NEWSWIRE) -- (via Blockchain Wire) ONI has created a BEP-20 ONI token on the Binance Smart Chain network, which will power an expanded ecosystem around its DeFi...
-
MIAMI, April 22, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the Company...
-
MIAMI, April 16, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today plans to...
-
Latest iteration of ProPILOT Assisti uses navigation data to more intuitively support driver on highways, including curves and exitsTraffic Sign Recognitionii offers speed-limit information to the...
-
MIAMI, March 12, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today CEO and...
-
Upcoming 2022 INFINITI QX60 features automaker's most advanced Intelligent All-Wheel-Drive system for enhanced capabilityInnovative, direct coupling all-wheel-drive system nearly instantly sends power...
-
MIAMI, March 03, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today it has...
-
MIAMI, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced plans to launch...
-
All-new 2022 INFINITI QX60 offers towing capacity up to 6,000 pounds1 on select gradesNew 9-speed automatic transmission and award-winning 295-hp, 3.5-liter V-6 combine to offer up to 20% increase in...
-
Ehave, Inc. to leverage data and AI to correlate biomarkers for the identification of psychedelic drug administration as a treatment for Chronic pain, Depression (major and persistent), PTSD, Bipolar...